利培酮联合艾司西酞普兰治疗慢性精神分裂症阴性症状的对照研究
【摘要】目的探讨利培酮联合艾司西酞普兰治疗慢性精神分裂症阴性症状的临床疗效以及安全性。方法将80例以阴性症状为主的慢性精神分裂症患者随机分为合用组和单用组, 疗程12周, 采用阳性和阴性症状量表(PANSS)和治疗中出现的症状量表(TESS)评定疗效和安全性。结果合用组显效率77.5%, 单用组显效率55%。治疗后两组PASS评分均较治疗前有显著性下降, 差异有统计学意义(P<0.01)。治疗后2、4、8、12周末, 合用组阴性因子分较单用组明显下降, 差异有统计学意义(P<0.05)。两组不良反应差异无统计学意义(P>0.05)。结论利培酮联合艾司西酞普兰治疗慢性精神分裂症阴性症状起效快、疗效好, 不良反应少。
【关键词】艾司西酞普兰；利培酮；慢性精神分裂症；阴性症状
Control study on escitalopram combined with risperidone in the treatment of negative symptoms of chronic schizophrenia patients LI Xin-feng. Xinyang Mental Hospital, Xinyang 464000, China
【Abstract】Objective To evaluate clinical efficacy and safety of escitalopram combined with risperidone in the treatment of negative symptoms of chronic schizophrenia paitents. Methods Divided 80 patients with predominantly negative symptoms of chronic schizophrenia into combined group(escitalopram combined risperdone) and control group(risperidone alone) with 12 weeks treatment. PANSS and TESS were used to assess the efficacy and safety respectively. Results The significant improvement rate in combined group was higher(77.5% ) than control group(55%), compared with before treatment, PANSS scores decreasedsignificantly after treatment(P<0.01). After 4 weeks treatment, the total scores and negative symptoms scores of PANSS significantly decreasaed in combined group compared to control group(P<0.05) There were no significant differences in side effects between two groups. Conclusion Escitalopram combined with risperidone in the treatment of chronic schizophrenia with negative symptoms show rapid response, ...
|
== 试读已结束，如需继续阅读敬请充值会员 ==
|
|
本站文章均为原创投稿，仅供下载参考，付费用户可查看完整且有格式内容！
(费用标准：38元/2月，98元/2年，微信支付秒开通！) |
| 升级为会员即可查阅全文 。如需要查阅全文，请 免费注册 或 登录会员 |
|
